InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Ogden Christopher. Director active across 1 company, notably CytomX Therapeutics, Inc.. Cumulatively, 14 disclosures have been logged. Split: 0 buy · 7 sells. Total volume traded: €126k. History available since 2 February 2023. The latest transaction was disclosed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 条申报中的 14 条
Ogden Christopher is a declarant linked to CytomX Therapeutics, Inc., where he serves as Chief Financial Officer. He has 14 filings in total, and across the 14 sampled filings between 2023-02-06 and 2026-06-17, the recorded activity is a sale, with sum_buy_eur at 0 and sum_sell_eur at 125957.